RSS

Celgene Corporation

Biotechnology company Obsidian Therapeutics is collaborating with major biopharma player Celgene to discover and develop novel, regulated cell therapies. Read more

News

In a major biopharmaceutical shake-up, Bristol-Myers Squibb has announced that it will acquire Celgene for $74 billion. Read more

News

The US Food and Drug Administration’s of Prescription Drug Promotion (OPDP) has called for integrated healthcare company Sanofi-aventis and global biopharmaceutical company Celgene, to stop broadcasting two of their TV adverts. Read more

News

Following a closed-door period, the UK's Cancer Drugs Fund is once again accepting new treatments. Read more

News

A £5.2 million ($8 million) milestone has been reached by Concert Pharmaceuticals and Celgene Corporation for the completion of a phase one clinical evaluation of CTP-730 Read more

News